Microbiota and urinary tumor immunity: Mechanisms, therapeutic implications, and future perspectives.
作者信息
Li Dengxiong, Wu Ruicheng, Yu Qingxin, Tuo Zhouting, Wang Jie, Yoo Koo Han, Wei Wuran, Yang Yubo, Ye Luxia, Guo Yiqing, Chaipanichkul Premkamon, Okoli Uzoamaka Adaobi, Poolman Toryn M, Burton Jeremy P, Cho William C, Heavey Susan, Feng Dechao
机构信息
Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.
Department of Pathology, Ningbo Clinical Pathology Diagnosis Center, Ningbo 315211, China.
出版信息
Chin J Cancer Res. 2024 Dec 30;36(6):596-615. doi: 10.21147/j.issn.1000-9604.2024.06.03.
Abstract
摘要
相似文献
1
Microbiota and urinary tumor immunity: Mechanisms, therapeutic implications, and future perspectives.微生物群与泌尿系统肿瘤免疫：机制、治疗意义及未来展望
Chin J Cancer Res. 2024 Dec 30;36(6):596-615. doi: 10.21147/j.issn.1000-9604.2024.06.03.
2
Microbiota—implications for immunity and transplantation.肠道菌群—对免疫和移植的影响。
Nat Rev Nephrol. 2015 Jun;11(6):342-53. doi: 10.1038/nrneph.2015.70. Epub 2015 May 12.
3
Intratumor microbiota in cancer pathogenesis and immunity: from mechanisms of action to therapeutic opportunities.肿瘤内微生物群在癌症发病机制和免疫中的作用：从作用机制到治疗机会。
Front Immunol. 2023 Oct 6;14:1269054. doi: 10.3389/fimmu.2023.1269054. eCollection 2023.
4
Microbiota modulate immune repertories in lung adenocarcinoma via microbiota-immunity interactive network.微生物群通过微生物群-免疫相互作用网络调节肺腺癌中的免疫库。
Transl Lung Cancer Res. 2024 Oct 31;13(10):2683-2697. doi: 10.21037/tlcr-24-393. Epub 2024 Oct 28.
5
Parasites and Microbiota: Dual Interactions and Therapeutic Perspectives.寄生虫与微生物群：双重相互作用及治疗前景
Microorganisms. 2024 Oct 16;12(10):2076. doi: 10.3390/microorganisms12102076.
6
The role of microbiome: a novel insight into urolithiasis.微生物组的作用：对尿石症的新认识。
Crit Rev Microbiol. 2023 Mar;49(2):177-196. doi: 10.1080/1040841X.2022.2045899. Epub 2022 Jul 1.
7
The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes.肠道微生物群与肿瘤免疫的串扰：对癌症进展和治疗结果的影响。
Front Immunol. 2023 Jan 16;13:1096551. doi: 10.3389/fimmu.2022.1096551. eCollection 2022.
8
The role of the gut microbiota in schizophrenia: Current and future perspectives.肠道微生物群在精神分裂症中的作用：当前和未来的视角。
World J Biol Psychiatry. 2018 Dec;19(8):571-585. doi: 10.1080/15622975.2018.1433878. Epub 2018 Feb 21.
9
The Interplay Between Cervicovaginal Microbial Dysbiosis and Cervicovaginal Immunity.宫颈阴道微生物失调与宫颈阴道免疫的相互作用。
Front Immunol. 2022 Mar 10;13:857299. doi: 10.3389/fimmu.2022.857299. eCollection 2022.
10
Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies.肠道微生物群影响免疫治疗反应：机制和治疗策略。
J Hematol Oncol. 2022 Apr 29;15(1):47. doi: 10.1186/s13045-022-01273-9.
引用本文的文献
1
Construction of a gene-metabolite-microbiome regulatory network reveals novel therapeutic targets in bladder cancer through multi-omics analysis.通过多组学分析构建基因-代谢物-微生物组调控网络揭示膀胱癌新的治疗靶点
Ann Med. 2025 Dec;57(1):2553220. doi: 10.1080/07853890.2025.2553220. Epub 2025 Sep 5.
2
Biomimetic nanovaccines in cancer therapy: mechanisms, efficacy, and clinical translation.癌症治疗中的仿生纳米疫苗：作用机制、疗效及临床转化
Mater Today Bio. 2025 Jul 18;34:102116. doi: 10.1016/j.mtbio.2025.102116. eCollection 2025 Oct.
3
A cross-sectional study on the effects of intravesical BCG on urinary microbiota in bladder cancer patients.一项关于膀胱内卡介苗对膀胱癌患者尿液微生物群影响的横断面研究。
Int Urol Nephrol. 2025 Jun 30. doi: 10.1007/s11255-025-04607-x.
4
Circulating metabolic biomarkers mediated causal relationship between gut microbiota and bladder cancer: a two-step mendelian randomization study.循环代谢生物标志物介导的肠道微生物群与膀胱癌之间的因果关系：一项两步孟德尔随机化研究。
Discov Oncol. 2025 May 23;16(1):877. doi: 10.1007/s12672-025-02618-9.
5
Cutting-Edge Advancements in the Antibiotics-Gut Microbiota-Urinary Tumour Axis.抗生素-肠道微生物群-泌尿系统肿瘤轴的前沿进展
Cell Prolif. 2025 May;58(5):e70023. doi: 10.1111/cpr.70023. Epub 2025 Mar 17.
本文引用的文献
1
Blautia coccoides and its metabolic products enhance the efficacy of bladder cancer immunotherapy by promoting CD8 T cell infiltration.脆弱拟杆菌及其代谢产物通过促进 CD8+T 细胞浸润增强膀胱癌免疫治疗的效果。
J Transl Med. 2024 Oct 24;22(1):964. doi: 10.1186/s12967-024-05762-y.
2
Tumor microbiota of renal cell carcinoma affects clinical prognosis by influencing the tumor immune microenvironment.肾细胞癌的肿瘤微生物群通过影响肿瘤免疫微环境来影响临床预后。
Heliyon. 2024 Sep 23;10(19):e38310. doi: 10.1016/j.heliyon.2024.e38310. eCollection 2024 Oct 15.
3
Dysbiosis in Human Urinary Microbiota May Differentiate Patients with a Bladder Cancer.人类尿液微生物组的失调可能可以区分膀胱癌患者。
Int J Mol Sci. 2024 Sep 21;25(18):10159. doi: 10.3390/ijms251810159.
4
Intratumoral microbiota as a novel prognostic indicator in bladder cancer.肿瘤内微生物群作为膀胱癌的一种新的预后指标。
Sci Rep. 2024 Sep 27;14(1):22198. doi: 10.1038/s41598-024-72918-7.
5
Causality investigation among gut microbiota, immune cells, and prostate diseases: a Mendelian randomization study.肠道微生物群、免疫细胞与前列腺疾病之间的因果关系研究：一项孟德尔随机化研究
Front Microbiol. 2024 Sep 11;15:1445304. doi: 10.3389/fmicb.2024.1445304. eCollection 2024.
6
The complex interplay of tumor-infiltrating cells in driving therapeutic resistance pathways.肿瘤浸润细胞在推动治疗抵抗途径中的复杂相互作用。
Cell Commun Signal. 2024 Aug 19;22(1):405. doi: 10.1186/s12964-024-01776-7.
7
Intestinal microbiota composition is predictive of radiotherapy-induced acute gastrointestinal toxicity in prostate cancer patients.肠道微生物组成可预测前列腺癌患者放疗诱导的急性胃肠道毒性。
EBioMedicine. 2024 Aug;106:105246. doi: 10.1016/j.ebiom.2024.105246. Epub 2024 Jul 18.
8
MyD88 Signaling Accompanied by Microbiota Changes Supports Urinary Bladder Carcinogenesis.MyD88 信号伴随微生物群变化支持膀胱癌发生。
Int J Mol Sci. 2024 Jun 29;25(13):7176. doi: 10.3390/ijms25137176.
9
Gut microbiota Parabacteroides distasonis enchances the efficacy of immunotherapy for bladder cancer by activating anti-tumor immune responses.肠道微生物拟杆菌属通过激活抗肿瘤免疫应答增强膀胱癌免疫治疗的疗效。
BMC Microbiol. 2024 Jul 3;24(1):237. doi: 10.1186/s12866-024-03372-8.
10
Interactions between oxidative stress and senescence in cancer: Mechanisms, therapeutic implications, and future perspectives.氧化应激与癌症衰老之间的相互作用：机制、治疗意义及未来展望。
Redox Biol. 2024 Jul;73:103208. doi: 10.1016/j.redox.2024.103208. Epub 2024 May 24.
Zotero 插件